Skip to main content
OpenTrials
Completed

NCT Number: NCT02783287

The Impact of Text Messaging on Medication Adherence and Exercise Regimen Among Post-myocardial Infarction Patients

The purpose of this study is to assess the impact of text message reminders on adherence to medications and exercise in patients recently discharged from the hospital after a myocardial infarction (MI).

Completed

Looking for future studies?

Notify Me

Key information

About this study

The Impact of Text Messaging on Medication Adherence and Exercise Regimen among Post-Myocardial Infarction Patients includes two single-center randomized control trials to assess the impact of text message reminds on adherence to medications and exercise regimen in patients recently discharged from the hospital after MI.

Recruitment conducted at Cambridge Cardiac Rehabilitation in Ontario, Canada for both the medication adherence and exercise trial. Potential study subjects are evaluated for inclusion and exclusion criteria, give written informed consent, and are randomized, in a 1:1 ratio, to either intervention or usual care (control).

Patients randomized to the intervention arm in the medication adherence trial receive an automated text message once per day at the time they are prescribed to take their medication. The text message does not contain any personal or pharmacological information.

Patients randomized to the intervention arm in the exercise adherence trial receive four text messages per day at 7:30 am, 12:00 pm, 6:00 pm, and 9:00 pm, reminding them to exercise for 30 minutes per day as per their health care provider.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Post-MI hospital discharge within 2 weeks
  • Enrolled in cardiac rehabilitation
  • Prescribed anti-platelets, beta-blockers, ACE-inhibitors or ARBs, and/or statins on 1x/day regimen (for medication adherence trial)
  • Prescribed exercise regimen (for exercise trial)
  • Ability to read and write English
  • Possession of a cell phone with text messaging capability

Exclusion criteria

  • Age < 18
  • Incarcerated individuals
  • Unable to read and write English
  • Not in possession of a cell phone
  • Patients prescribed medication regimen > 1x/day

Treatment and study plan

Text message reminder for medication adherence

Behavioral

Patients randomized to this arm receive one text message per day (at the scheduled time) reminding them to take their medication.

Text message reminder for exercise regimen

Behavioral

Patients randomized to this arm receive 4 daily text messages reminding them to exercise for 30 minutes per day.

Primary outcomes

  1. Medication adherence

    Time frame: 12 months

    Average medication adherence over 12 months after randomization, assessed with self-reported logs

  2. Exercise frequency

    Time frame: 12 months

    Average frequency of exercise over 12 months after randomization, assessed with self-reported logs

Secondary outcomes

  1. Exercise duration

    Time frame: 12 months

    Average duration of exercise assessed by BRUCE protocol

  2. Full medication adherence

    Time frame: 12 months

    Average medication adherence over 12 months greater than .80

Sponsors and collaborators

Lead sponsor

Brigham and Women's Hospital

Other

Collaborators

  • University of Waterloo

Registry information

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
May 26, 2016
Registry last updated
May 26, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.